Mori, M.; Stelitano, G.; Griego, A.; Chiarelli, L.R.; Cazzaniga, G.; Gelain, A.; Pini, E.; Camera, M.; Canzano, P.; Fumagalli, A.;
et al. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. Pharmaceuticals 2022, 15, 992.
https://doi.org/10.3390/ph15080992
AMA Style
Mori M, Stelitano G, Griego A, Chiarelli LR, Cazzaniga G, Gelain A, Pini E, Camera M, Canzano P, Fumagalli A,
et al. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. Pharmaceuticals. 2022; 15(8):992.
https://doi.org/10.3390/ph15080992
Chicago/Turabian Style
Mori, Matteo, Giovanni Stelitano, Anna Griego, Laurent R. Chiarelli, Giulia Cazzaniga, Arianna Gelain, Elena Pini, Marina Camera, Paola Canzano, Andrea Fumagalli,
and et al. 2022. "Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections" Pharmaceuticals 15, no. 8: 992.
https://doi.org/10.3390/ph15080992
APA Style
Mori, M., Stelitano, G., Griego, A., Chiarelli, L. R., Cazzaniga, G., Gelain, A., Pini, E., Camera, M., Canzano, P., Fumagalli, A., Scarpa, E., Cordiglieri, C., Rizzello, L., Villa, S., & Meneghetti, F.
(2022). Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. Pharmaceuticals, 15(8), 992.
https://doi.org/10.3390/ph15080992
